These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

332 related items for PubMed ID: 22391103

  • 1. Mode of peroxisome proliferator-activated receptor γ activation by luteolin.
    Puhl AC, Bernardes A, Silveira RL, Yuan J, Campos JL, Saidemberg DM, Palma MS, Cvoro A, Ayers SD, Webb P, Reinach PS, Skaf MS, Polikarpov I.
    Mol Pharmacol; 2012 Jun; 81(6):788-99. PubMed ID: 22391103
    [Abstract] [Full Text] [Related]

  • 2. Luteolin inhibits adipogenic differentiation by regulating PPARgamma activation.
    Park HS, Kim SH, Kim YS, Ryu SY, Hwang JT, Yang HJ, Kim GH, Kwon DY, Kim MS.
    Biofactors; 2009 Jun; 35(4):373-9. PubMed ID: 19353690
    [Abstract] [Full Text] [Related]

  • 3. Medium chain fatty acids are selective peroxisome proliferator activated receptor (PPAR) γ activators and pan-PPAR partial agonists.
    Liberato MV, Nascimento AS, Ayers SD, Lin JZ, Cvoro A, Silveira RL, Martínez L, Souza PC, Saidemberg D, Deng T, Amato AA, Togashi M, Hsueh WA, Phillips K, Palma MS, Neves FA, Skaf MS, Webb P, Polikarpov I.
    PLoS One; 2012 Jun; 7(5):e36297. PubMed ID: 22649490
    [Abstract] [Full Text] [Related]

  • 4. Hydrogen/deuterium-exchange (H/D-Ex) of PPARgamma LBD in the presence of various modulators.
    Hamuro Y, Coales SJ, Morrow JA, Molnar KS, Tuske SJ, Southern MR, Griffin PR.
    Protein Sci; 2006 Aug; 15(8):1883-92. PubMed ID: 16823031
    [Abstract] [Full Text] [Related]

  • 5. A novel selective peroxisome proliferator-activator receptor-gamma modulator-SPPARgammaM5 improves insulin sensitivity with diminished adverse cardiovascular effects.
    Chang CH, McNamara LA, Wu MS, Muise ES, Tan Y, Wood HB, Meinke PT, Thompson JR, Doebber TW, Berger JP, McCann ME.
    Eur J Pharmacol; 2008 Apr 14; 584(1):192-201. PubMed ID: 18346728
    [Abstract] [Full Text] [Related]

  • 6. A selective peroxisome proliferator-activated receptor gamma modulator with distinct fat cell regulation properties.
    Fujimura T, Kimura C, Oe T, Takata Y, Sakuma H, Aramori I, Mutoh S.
    J Pharmacol Exp Ther; 2006 Aug 14; 318(2):863-71. PubMed ID: 16682454
    [Abstract] [Full Text] [Related]

  • 7. Mechanisms of peroxisome proliferator activated receptor γ regulation by non-steroidal anti-inflammatory drugs.
    Puhl AC, Milton FA, Cvoro A, Sieglaff DH, Campos JC, Bernardes A, Filgueira CS, Lindemann JL, Deng T, Neves FA, Polikarpov I, Webb P.
    Nucl Recept Signal; 2015 Aug 14; 13():e004. PubMed ID: 26445566
    [Abstract] [Full Text] [Related]

  • 8. Structural basis for differential activities of enantiomeric PPARγ agonists: Binding of S35 to the alternate site.
    Jang JY, Koh M, Bae H, An DR, Im HN, Kim HS, Yoon JY, Yoon HJ, Han BW, Park SB, Suh SW.
    Biochim Biophys Acta Proteins Proteom; 2017 Jun 14; 1865(6):674-681. PubMed ID: 28342850
    [Abstract] [Full Text] [Related]

  • 9. Structural insight into PPARgamma activation through covalent modification with endogenous fatty acids.
    Waku T, Shiraki T, Oyama T, Fujimoto Y, Maebara K, Kamiya N, Jingami H, Morikawa K.
    J Mol Biol; 2009 Jan 09; 385(1):188-99. PubMed ID: 18977231
    [Abstract] [Full Text] [Related]

  • 10. Novel transcriptome profiling analyses demonstrate that selective peroxisome proliferator-activated receptor γ (PPARγ) modulators display attenuated and selective gene regulatory activity in comparison with PPARγ full agonists.
    Tan Y, Muise ES, Dai H, Raubertas R, Wong KK, Thompson GM, Wood HB, Meinke PT, Lum PY, Thompson JR, Berger JP.
    Mol Pharmacol; 2012 Jul 09; 82(1):68-79. PubMed ID: 22496518
    [Abstract] [Full Text] [Related]

  • 11. Discovery of a novel selective PPARγ ligand with partial agonist binding properties by integrated in silico/in vitro work flow.
    Kouskoumvekaki I, Petersen RK, Fratev F, Taboureau O, Nielsen TE, Oprea TI, Sonne SB, Flindt EN, Jónsdóttir SÓ, Kristiansen K.
    J Chem Inf Model; 2013 Apr 22; 53(4):923-37. PubMed ID: 23432662
    [Abstract] [Full Text] [Related]

  • 12. PAM-1616, a selective peroxisome proliferator-activated receptor γ modulator with preserved anti-diabetic efficacy and reduced adverse effects.
    Kim MK, Chae YN, Choi SH, Moon HS, Son MH, Bae MH, Choi HH, Hur Y, Kim E, Park YH, Park CS, Kim JG, Lim JI, Shin CY.
    Eur J Pharmacol; 2011 Jan 15; 650(2-3):673-81. PubMed ID: 20974124
    [Abstract] [Full Text] [Related]

  • 13. The dipeptide H-Trp-Glu-OH shows highly antagonistic activity against PPARgamma: bioassay with molecular modeling simulation.
    Ye F, Zhang ZS, Luo HB, Shen JH, Chen KX, Shen X, Jiang HL.
    Chembiochem; 2006 Jan 15; 7(1):74-82. PubMed ID: 16317783
    [Abstract] [Full Text] [Related]

  • 14. Very low density lipoprotein receptor promotes adipocyte differentiation and mediates the proadipogenic effect of peroxisome proliferator-activated receptor gamma agonists.
    Tao H, Hajri T.
    Biochem Pharmacol; 2011 Dec 15; 82(12):1950-62. PubMed ID: 21924248
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. PAR-1622 is a selective peroxisome proliferator-activated receptor gamma partial activator with preserved antidiabetic efficacy and broader safety profile for fluid retention.
    Kim MK, Chae YN, Kim HS, Choi SH, Son MH, Kim SH, Kim JK, Moon HS, Park SK, Shin YA, Kim JG, Lee CH, Lim JI, Shin CY.
    Arch Pharm Res; 2009 May 15; 32(5):721-7. PubMed ID: 19471887
    [Abstract] [Full Text] [Related]

  • 18. PPARγ partial agonist GQ-16 strongly represses a subset of genes in 3T3-L1 adipocytes.
    Milton FA, Cvoro A, Amato AA, Sieglaff DH, Filgueira CS, Arumanayagam AS, de Lima Mdo C, Pitta IR, de Assis Rocha Neves F, Webb P.
    Biochem Biophys Res Commun; 2015 Aug 28; 464(3):718-23. PubMed ID: 26168725
    [Abstract] [Full Text] [Related]

  • 19. Magnolol enhances adipocyte differentiation and glucose uptake in 3T3-L1 cells.
    Choi SS, Cha BY, Lee YS, Yonezawa T, Teruya T, Nagai K, Woo JT.
    Life Sci; 2009 Jun 19; 84(25-26):908-14. PubMed ID: 19376135
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.